Non-invasive fibrosis algorithms are clinically useful for excluding cirrhosis in prisoners living with hepatitis C

Timothy Papaluca1, Anne Craigie1, Lucy McDonald1

  • 1Department of Gastroenterology, St Vincent's Hospital and the University of Melbourne, Melbourne, Australia.

Plos One
|November 18, 2020
PubMed

Insights

Hepatitis C (HCV) cirrhosis can be reliably excluded in prisoners using the AST-to-platelet ratio index (APRI) and FIB-4 scores. These non-invasive markers can reduce the need for transient elastography, simplifying HCV care in correctional facilities.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Prison-based Hepatitis C Virus (HCV) treatment is hindered by barriers, including limited access to transient elastography for cirrhosis assessment.
  • Non-invasive markers like the AST-to-platelet ratio index (APRI) and FIB-4 scores show promise in excluding cirrhosis in general populations.

Purpose of the Study:

  • To evaluate the performance of APRI and FIB-4 scores in identifying cirrhosis among a large cohort of prisoners with HCV infection.
  • To assess the potential of these scores to reduce the reliance on transient elastography in this population.

Main Methods:

  • Retrospective cohort study of 1007 prisoners with HCV infection.
  • Analysis of sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) of APRI and FIB-4 for cirrhosis, using transient elastography as the reference standard.
  • Exploration of age thresholds as a potential trigger for transient elastography.

Main Results:

  • APRI (cut-off 1.0) and FIB-4 (cut-off 1.45) demonstrated high NPVs (96.1% and 96.6%, respectively) for cirrhosis.
  • Utilizing these scores for triage could decrease the need for transient elastography by 71%.
  • Age ≤35 years alone had a NPV of 96.5% for cirrhosis, and in individuals >35 years, APRI alone showed a high NPV (>95%).

Conclusions:

  • APRI and FIB-4 scores are effective tools for excluding cirrhosis in the prison population.
  • These non-invasive markers can significantly reduce the requirement for transient elastography, streamlining the care pathway for incarcerated individuals with HCV.
Abstract